Heinrich Jakob Audebert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Heinrich Jakob Audebert has a total of 570 co-authors. Here are the top co-authors by number of shared publications:
- Christian H. Nolte
Department of Neurology with Experimental Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany
14 shared publications - Matthias Endres
Center for Stroke Research Berlin (CSB), Charité-Universitätsmedizin Berlin, Berlin, Germany
11 shared publications - Jan Friedrich Scheitz
Department of Neurology with Experimental Neurology and Center for Stroke Research Berlin, Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany
7 shared publications Martin Ebinger
Klinik für Neurologie, Medical Park Berlin Humboldtmühle, Berlin, Germany 4
6 shared publicationsMatthias Endres
Center for Stroke Research Berlin, Charité – Universitätsmedizin Berlin, Berlin, Germany 2
6 shared publicationsMatthias Wendt
Klinik für Neurologie mit Stroke Unit und Frührehabilitation, Unfallkrankenhaus Berlin, Germany
6 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Springer Nature in Neurological Research and Practice
- Vol. 8 (1) , 92
Stroke-CORE: master study protocol of the national cohort of the specialty network stroke within the network university medicine in Germany
Introduction: Although Germany has a strong history of stroke research, it currently lacks a national harmonised infrastructure for clinical stroke research. To address this gap, the stroke-specific Specialty Network (SN Stroke) of the Network University Medicine (NUM) was established as a comprehensive research platform. Hereby we present the protocol of the Stroke-CORE cohort (COhort for REsearch in Stroke) within SN Stroke enrolling a large representative cohort of patients with acute ischeamic stroke or intracerebral haemorrhage in Germany. Methods: Stroke-CORE is a national, prospective, longitudinal, multi-centre cohort study with a decentralised biobank, structured as a modular umbrella protocol. Adult patients with acute ischaemic stroke or intracerebral haemorrhage, and paediatric stroke patients are enrolled at participating hospitals. Data collection follows four adaptive levels, ranging from a core clinical data set (Level 1) to modules covering the whole stroke care pathway (Level 2), biosamples (Level 3), and voluntary additional modules (Level 4), with follow-up at discharge, 90 days, 180 days (optional), and annually. Enrolment started in August 2026 across 12 initial sites, with a target of 12,750 patients being recruited by 2030. Perspective: Stroke-CORE represents a nationally harmonised cohort spanning prehospital care, acute treatment, rehabilitation, prevention, aftercare, and paediatric stroke. Its adaptive modular design allows continuous expansion with new modules, data streams, and biobanking initiatives without protocol revision. As a sustainable national research platform, Stroke-CORE aims to address key knowledge gaps, facilitate recruitment for clinical trials, and accelerate translational, clinical and outcomes research. Trial registration: The protocol is registered at German Clinical Trials Register (DRKS00039775, July 8th, 2026).
- 30 October 2026
- Published by Springer Nature in Neurological Research and Practice
- Vol. 8 (1) , 92
Open AccessStroke-CORE: master study protocol of the national cohort of the specialty network stroke within the network university medicine in Germany
Introduction: Although Germany has a strong history of stroke research, it currently lacks a national harmonised infrastructure for clinical stroke research. To address this gap, the stroke-specific Specialty Network (SN Stroke) of the Network University Medicine (NUM) was established as a comprehensive research platform. Hereby we present the protocol of the Stroke-CORE cohort (COhort for REsearch in Stroke) within SN Stroke enrolling a large representative cohort of patients with acute ischeamic stroke or intracerebral haemorrhage in Germany. Methods: Stroke-CORE is a national, prospective, longitudinal, multi-centre cohort study with a decentralised biobank, structured as a modular umbrella protocol. Adult patients with acute ischaemic stroke or intracerebral haemorrhage, and paediatric stroke patients are enrolled at participating hospitals. Data collection follows four adaptive levels, ranging from a core clinical data set (Level 1) to modules covering the whole stroke care pathway (Level 2), biosamples (Level 3), and voluntary additional modules (Level 4), with follow-up at discharge, 90 days, 180 days (optional), and annually. Enrolment started in August 2026 across 12 initial sites, with a target of 12,750 patients being recruited by 2030. Perspective: Stroke-CORE represents a nationally harmonised cohort spanning prehospital care, acute treatment, rehabilitation, prevention, aftercare, and paediatric stroke. Its adaptive modular design allows continuous expansion with new modules, data streams, and biobanking initiatives without protocol revision. As a sustainable national research platform, Stroke-CORE aims to address key knowledge gaps, facilitate recruitment for clinical trials, and accelerate translational, clinical and outcomes research. Trial registration: The protocol is registered at German Clinical Trials Register (DRKS00039775, July 8th, 2026).
- 1 September 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (17)
Systematic Review on Noncomputed Tomography‐Based Technologies for Prehospital Stroke Diagnosis
Effects of stroke therapies area highly time dependent but onset‐to‐treatment times for recanalizing treatment are mostly beyond optimal time windows. Mobile stroke units shorten time to treatment and improve functional outcome. However, costs and logistical demands preclude their widespread use. There is a pressing need for alternative prehospital diagnostic tools that enable early, on‐site treatment and facilitate targeted transport in patients needing interventional therapies. This systematic review aimed at examining the current landscape of noncomputed tomography‐based technologies for prehospital stroke diagnosis. We conducted a literature search of original research papers on predetermined technologies and through systematic scouting on PubMed and included papers in English found through MEDLINE and Embase, published until October 2025. Relevant papers not identified by the systematic search but known to the authors were included and indicated as such. The final review included 105 publications evaluating innovations in microwave, transcranial eddy current damping, volumetric impedance phase shift spectroscopy, ultrasound, magnetic resonance imaging, electroencephalography, near‐infrared spectroscopy, blood biomarkers, telemedicine, and artificial intelligence. Each technology's potentials, limitations, and clinical feasibility for enhancing prehospital diagnosis and therapeutic and monitoring utility were assessed. No single technology provides capabilities similar to noncomputed tomography in terms of detection and differentiation of ischemic and hemorrhagic stroke. A combination of ultrasound and near‐infrared spectroscopy may complement each other in hemorrhage detection. Electroencephalography shows most promise in identifying large vessel occlusion. Telemedicine can be used for reliable prehospital stroke assessment. Future research should target both the improvement of individual technologies as well as combining different modalities.
- 1 September 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (17)
Systematic Review on Noncomputed Tomography‐Based Technologies for Prehospital Stroke Diagnosis
Effects of stroke therapies area highly time dependent but onset‐to‐treatment times for recanalizing treatment are mostly beyond optimal time windows. Mobile stroke units shorten time to treatment and improve functional outcome. However, costs and logistical demands preclude their widespread use. There is a pressing need for alternative prehospital diagnostic tools that enable early, on‐site treatment and facilitate targeted transport in patients needing interventional therapies. This systematic review aimed at examining the current landscape of noncomputed tomography‐based technologies for prehospital stroke diagnosis. We conducted a literature search of original research papers on predetermined technologies and through systematic scouting on PubMed and included papers in English found through MEDLINE and Embase, published until October 2025. Relevant papers not identified by the systematic search but known to the authors were included and indicated as such. The final review included 105 publications evaluating innovations in microwave, transcranial eddy current damping, volumetric impedance phase shift spectroscopy, ultrasound, magnetic resonance imaging, electroencephalography, near‐infrared spectroscopy, blood biomarkers, telemedicine, and artificial intelligence. Each technology's potentials, limitations, and clinical feasibility for enhancing prehospital diagnosis and therapeutic and monitoring utility were assessed. No single technology provides capabilities similar to noncomputed tomography in terms of detection and differentiation of ischemic and hemorrhagic stroke. A combination of ultrasound and near‐infrared spectroscopy may complement each other in hemorrhage detection. Electroencephalography shows most promise in identifying large vessel occlusion. Telemedicine can be used for reliable prehospital stroke assessment. Future research should target both the improvement of individual technologies as well as combining different modalities.
- 28 April 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (8) , e214831
Functional Outcome Following Blood Pressure Drops Within 24 Hours After Successful Mechanical Thrombectomy
Background and ObjectivesThe optimal target blood pressure (BP) during and after mechanical thrombectomy (MT) for acute ischemic stroke remains uncertain. While BP drops during MT are associated wi...
- 28 April 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (8) , e214831
Functional Outcome Following Blood Pressure Drops Within 24 Hours After Successful Mechanical Thrombectomy
Background and ObjectivesThe optimal target blood pressure (BP) during and after mechanical thrombectomy (MT) for acute ischemic stroke remains uncertain. While BP drops during MT are associated wi...
- Open Access
- 6 April 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (4)
One-year functional outcome of the Flying Intervention Team versus patient interhospital transfer in acute ischaemic stroke
Introduction: Endovascular thrombectomy is highly effective for large vessel occlusion strokes, yet timely access remains challenging in remote areas. The Flying Intervention Team study demonstrated that dispatching a neurointerventionist team to peripheral hospitals reduces time to treatment. This study evaluates 12-month functional outcomes of enrolled patients. Patients and methods: This is a secondary analysis of a multicentre pseudo-randomised controlled intervention study comparing 2 systems of care in alternating weeks. The study was conducted in 13 nonurban primary stroke centres in Bavaria, Germany. Of 157 patients enrolled between February 2018 and October 2019, 146 had available 12-month follow-up information. Patients were treated either by the flying team or after interhospital transfer to a referral centre. Primary outcome was the modified Rankin Scale (mRS) score at 12 months in the intention-to-treat analysis. Secondary outcomes included quality of life, activities of daily living and mortality. Results: Overall, 146 patients were included (median [IQR] age, 75 [66–80] years; 79 [54%] women), 70 in the flying team group and 76 in the transfer group. Median decision-to-puncture time was 89 min shorter in the flying team group. No significant differences were found in successful reperfusion and complication rates. mRS scores at 12 months favoured the flying team (3 [IQR 1–6] vs 4 [2–6]; adjusted common odds ratio, 2.03; 95% CI, 1.09–3.84). Surviving patients had significantly better quality of life (EQ-5D mean [SD] utility score, 0.79 [0.24] vs 0.68 [0.31]). No significant differences were observed in Barthel index or mortality. Discussion and conclusion: In rural stroke patients, deployment of a flying team was associated with better functional outcomes at 12 months. These findings reinforce the potential for broader implementation of the model to increase equitable access to stroke care.
- 6 April 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (4)
Open AccessOne-year functional outcome of the Flying Intervention Team versus patient interhospital transfer in acute ischaemic stroke
Introduction: Endovascular thrombectomy is highly effective for large vessel occlusion strokes, yet timely access remains challenging in remote areas. The Flying Intervention Team study demonstrated that dispatching a neurointerventionist team to peripheral hospitals reduces time to treatment. This study evaluates 12-month functional outcomes of enrolled patients. Patients and methods: This is a secondary analysis of a multicentre pseudo-randomised controlled intervention study comparing 2 systems of care in alternating weeks. The study was conducted in 13 nonurban primary stroke centres in Bavaria, Germany. Of 157 patients enrolled between February 2018 and October 2019, 146 had available 12-month follow-up information. Patients were treated either by the flying team or after interhospital transfer to a referral centre. Primary outcome was the modified Rankin Scale (mRS) score at 12 months in the intention-to-treat analysis. Secondary outcomes included quality of life, activities of daily living and mortality. Results: Overall, 146 patients were included (median [IQR] age, 75 [66–80] years; 79 [54%] women), 70 in the flying team group and 76 in the transfer group. Median decision-to-puncture time was 89 min shorter in the flying team group. No significant differences were found in successful reperfusion and complication rates. mRS scores at 12 months favoured the flying team (3 [IQR 1–6] vs 4 [2–6]; adjusted common odds ratio, 2.03; 95% CI, 1.09–3.84). Surviving patients had significantly better quality of life (EQ-5D mean [SD] utility score, 0.79 [0.24] vs 0.68 [0.31]). No significant differences were observed in Barthel index or mortality. Discussion and conclusion: In rural stroke patients, deployment of a flying team was associated with better functional outcomes at 12 months. These findings reinforce the potential for broader implementation of the model to increase equitable access to stroke care.
- Open Access
- 17 March 2026
- Published by Springer Nature in Air Quality, Atmosphere & Health
- Vol. 19 (4) , 71
The short-term association of PM2.5 and stroke: a time-stratified case-crossover study in Berlin, Germany
Exposure to fine particulate matter (PM 2.5 ) is a major, potentially preventable contributor to cardiovascular disease and death. PM 2.5 levels in many urban regions, including Berlin, exceed recommended thresholds. We assessed whether short-term PM 2.5 exposure is associated with ischemic stroke and transient ischemic attacks (TIA) in Berlin, Germany (2017–2020). We linked a population-based stroke registry with hourly PM 2.5 and meteorological measurements and applied a time-stratified case-crossover design with conditional logistic regression, adjusting for meteorological and time-varying factors (public holidays, pandemic period indicator). Associations were estimated at symptom onset and for the preceding 36 h using hourly lags. Among 9,565 ischemic stroke and TIA cases, a one-standard-deviation increase in PM 2.5 (10.28 µg/m 3 ) increased the odds of stroke occurrence by 2% (adjusted OR (aOR) 1.020, 95% CI [0.994, 1.047]). Lagged estimates showed a wave-like pattern with irregular peaks, whereby the second largest estimate occurred 18 h before symptom onset (aOR = 1.015, 95% CI [0.989, 1.042]). These findings are consistent with previously reported adverse short-term cerebrovascular effects of PM 2.5 . Although associations were modest and imprecise, PM 2.5 exposure is widespread and largely unavoidable in urban settings, so further reductions may yield population health benefits. This study investigated hourly lagged exposure, indicating that associations vary preceding symptom onset. Replication and pooled multi-city analyses with comparable high-resolution data are needed to more precisely identify critical exposure windows and to quantify benefits of further PM 2.5 reductions under tightened air quality guidelines.
- 17 March 2026
- Published by Springer Nature in Air Quality, Atmosphere & Health
- Vol. 19 (4) , 71
Open AccessThe short-term association of PM2.5 and stroke: a time-stratified case-crossover study in Berlin, Germany
Exposure to fine particulate matter (PM 2.5 ) is a major, potentially preventable contributor to cardiovascular disease and death. PM 2.5 levels in many urban regions, including Berlin, exceed recommended thresholds. We assessed whether short-term PM 2.5 exposure is associated with ischemic stroke and transient ischemic attacks (TIA) in Berlin, Germany (2017–2020). We linked a population-based stroke registry with hourly PM 2.5 and meteorological measurements and applied a time-stratified case-crossover design with conditional logistic regression, adjusting for meteorological and time-varying factors (public holidays, pandemic period indicator). Associations were estimated at symptom onset and for the preceding 36 h using hourly lags. Among 9,565 ischemic stroke and TIA cases, a one-standard-deviation increase in PM 2.5 (10.28 µg/m 3 ) increased the odds of stroke occurrence by 2% (adjusted OR (aOR) 1.020, 95% CI [0.994, 1.047]). Lagged estimates showed a wave-like pattern with irregular peaks, whereby the second largest estimate occurred 18 h before symptom onset (aOR = 1.015, 95% CI [0.989, 1.042]). These findings are consistent with previously reported adverse short-term cerebrovascular effects of PM 2.5 . Although associations were modest and imprecise, PM 2.5 exposure is widespread and largely unavoidable in urban settings, so further reductions may yield population health benefits. This study investigated hourly lagged exposure, indicating that associations vary preceding symptom onset. Replication and pooled multi-city analyses with comparable high-resolution data are needed to more precisely identify critical exposure windows and to quantify benefits of further PM 2.5 reductions under tightened air quality guidelines.
- Open Access
- 1 January 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (1)
Intracranial haemorrhage without early clinical deterioration after mechanical thrombectomy: rethinking the “asymptomatic” label
Introduction: Intracranial haemorrhage (ICH) is a common complication following endovascular therapy (EVT) for ischaemic stroke. While symptomatic ICH (sICH) is known to worsen outcomes, the impact of ICH without early neurological deterioration (END), commonly referred to as “asymptomatic” (aICH), remains controversial. This study aimed to assess imaging patterns of aICH and its effect on clinical outcomes. Patients and methods: This study used data from the prospective, multicentre German Stroke Registry-Endovascular Treatment. Bleedings were assessed on follow-up imaging at 24 hours applying the Heidelberg Bleeding Classification. European Cooperative Acute Stroke Study III (ECASS)-III criteria were used to stratify patients into (1) no ICH, (2) aICH and (3) sICH. The primary outcome was functional independence (mRS ≤ 2) at 3 months. Secondary outcomes included mRS shift and 3-month mortality. Results: Among 4834 patients with EVT (median age 76, 51% female, median NIHSS 14), ICH occurred in 13.2% (aICH: 9.7%, sICH: 3.5%). Haemorrhage patterns differed, with sICH being more often parenchymal (48.2% vs 34.6%), multicompartmental (34.1% vs 20.2%) and involving the ventricular system (18.8% vs 7.6%), while aICH were predominantly haemorrhagic transformation (34.6% vs 21.8%). Functional independence at 90 days was reached by 40.0% (no ICH), 25.4% (aICH; adjusted odds ratio [aOR] 0.43 [0.32–0.58]) and 6.5% (sICH; aOR 0.06 [0.03–0.14]), respectively. aICH was associated with worse overall recovery (mRS shift adjusted common OR 0.51 [0.41–0.63]) and higher 90-day mortality (35.5% vs 24.9%; aOR 1.90 [1.44–2.51]), when compared to no ICH. Conclusion: ICH after EVT was associated with worse functional recovery and higher mortality, even in the absence of END. Given these results, the term “asymptomatic ICH” warrants reconsideration.
- 1 January 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (1)
Open AccessIntracranial haemorrhage without early clinical deterioration after mechanical thrombectomy: rethinking the “asymptomatic” label
Introduction: Intracranial haemorrhage (ICH) is a common complication following endovascular therapy (EVT) for ischaemic stroke. While symptomatic ICH (sICH) is known to worsen outcomes, the impact of ICH without early neurological deterioration (END), commonly referred to as “asymptomatic” (aICH), remains controversial. This study aimed to assess imaging patterns of aICH and its effect on clinical outcomes. Patients and methods: This study used data from the prospective, multicentre German Stroke Registry-Endovascular Treatment. Bleedings were assessed on follow-up imaging at 24 hours applying the Heidelberg Bleeding Classification. European Cooperative Acute Stroke Study III (ECASS)-III criteria were used to stratify patients into (1) no ICH, (2) aICH and (3) sICH. The primary outcome was functional independence (mRS ≤ 2) at 3 months. Secondary outcomes included mRS shift and 3-month mortality. Results: Among 4834 patients with EVT (median age 76, 51% female, median NIHSS 14), ICH occurred in 13.2% (aICH: 9.7%, sICH: 3.5%). Haemorrhage patterns differed, with sICH being more often parenchymal (48.2% vs 34.6%), multicompartmental (34.1% vs 20.2%) and involving the ventricular system (18.8% vs 7.6%), while aICH were predominantly haemorrhagic transformation (34.6% vs 21.8%). Functional independence at 90 days was reached by 40.0% (no ICH), 25.4% (aICH; adjusted odds ratio [aOR] 0.43 [0.32–0.58]) and 6.5% (sICH; aOR 0.06 [0.03–0.14]), respectively. aICH was associated with worse overall recovery (mRS shift adjusted common OR 0.51 [0.41–0.63]) and higher 90-day mortality (35.5% vs 24.9%; aOR 1.90 [1.44–2.51]), when compared to no ICH. Conclusion: ICH after EVT was associated with worse functional recovery and higher mortality, even in the absence of END. Given these results, the term “asymptomatic ICH” warrants reconsideration.
- Open Access
- 1 January 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (1)
Myocardial injury in patients with acute ischemic stroke: Prevalence and types of triggers of myocardial demand ischemia
Introduction: Acute myocardial injury occurs in about every fourth patient in the early phase after ischemic stroke. It may be caused by an imbalance between myocardial oxygen supply and demand, potentially leading to type 2 myocardial infarction (MI). However, little is known about the prevalence of potential triggers of such demand ischemia in acute stroke. Patients and methods: Consecutive patients with and without post-stroke acute myocardial injury (elevated high-sensitivity cardiac troponin T [hs-cTnT] levels with a rise/fall >20%) were matched for age and sex and retrospectively screened for presence of predefined triggering conditions of myocardial demand ischemia and fulfillment of diagnostic criteria for acute MI. Results: Among 508 stroke patients analyzed (median age 81 [73–86] years, 52% female), predefined potential triggers of demand ischemia were present in 107/254 (42%) patients with acute myocardial injury and in 61/254 (24%) matched controls (adjusted OR 2.30, 95%CI 1.51–3.52, p < 0.001). Patients with a trigger were older, more often female, had more severe strokes, and more often insular cortex involvement. The most prevalent triggers were respiratory failure, sustained hypertension, supraventricular tachyarrhythmia, and hemodynamic shock. MI criteria were fulfilled in 44/254 (17%) patients with acute myocardial injury including 27/44 (61.4%) with a trigger of demand ischemia (i.e. suspected type 2 MI). Conclusions: Conditions triggering a myocardial oxygen demand/supply mismatch are highly prevalent in patients with acute myocardial injury detected after stroke, notably in those fulfilling the criteria of acute MI. Stroke-specific aspects such as stroke severity or lesion location may play a role in the development of such triggers.
- 1 January 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (1)
Open AccessMyocardial injury in patients with acute ischemic stroke: Prevalence and types of triggers of myocardial demand ischemia
Introduction: Acute myocardial injury occurs in about every fourth patient in the early phase after ischemic stroke. It may be caused by an imbalance between myocardial oxygen supply and demand, potentially leading to type 2 myocardial infarction (MI). However, little is known about the prevalence of potential triggers of such demand ischemia in acute stroke. Patients and methods: Consecutive patients with and without post-stroke acute myocardial injury (elevated high-sensitivity cardiac troponin T [hs-cTnT] levels with a rise/fall >20%) were matched for age and sex and retrospectively screened for presence of predefined triggering conditions of myocardial demand ischemia and fulfillment of diagnostic criteria for acute MI. Results: Among 508 stroke patients analyzed (median age 81 [73–86] years, 52% female), predefined potential triggers of demand ischemia were present in 107/254 (42%) patients with acute myocardial injury and in 61/254 (24%) matched controls (adjusted OR 2.30, 95%CI 1.51–3.52, p < 0.001). Patients with a trigger were older, more often female, had more severe strokes, and more often insular cortex involvement. The most prevalent triggers were respiratory failure, sustained hypertension, supraventricular tachyarrhythmia, and hemodynamic shock. MI criteria were fulfilled in 44/254 (17%) patients with acute myocardial injury including 27/44 (61.4%) with a trigger of demand ischemia (i.e. suspected type 2 MI). Conclusions: Conditions triggering a myocardial oxygen demand/supply mismatch are highly prevalent in patients with acute myocardial injury detected after stroke, notably in those fulfilling the criteria of acute MI. Stroke-specific aspects such as stroke severity or lesion location may play a role in the development of such triggers.
- Open Access
- 1 December 2025
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 10 (4) , 1328-1336
Off-label thrombolysis in acute ischemic stroke patients: Frequencies and outcome compared to on-label and no treatment
Background: Intravenous thrombolysis (IVT) is not approved for acute ischemic stroke in certain patient groups due to in- and exclusion criteria from mostly early clinical trials. In a real-life setting, we analyzed frequencies, outcomes and complications of off-label-IVT compared to on-label-IVT and no IVT to contribute to rational decision-making regarding patient selection for IVT. Methods: Patients in the Berlin Specific Acute Therapy in Ischemic or hAemorrhagic stroke with Long-term follow-up registry were divided into three groups (on-label, off-label, non-IVT-treated). Off-label criteria were age > 80 years, time from onset >4.5 h, mild (National Institutes of Health Stroke Scale [NIHSS] < 5) or severe (NIHSS > 25) stroke, and a history of prior stroke and diabetes mellitus, as those criteria applied during the study period. Outcomes of interest were the 90-day modified Rankin Scale (mRS), symptomatic intracranial hemorrhage (sICH), in-hospital- and 90-day-mortality. After multiple imputation, we performed multivariable logistic regression to calculate adjusted common odds ratios (cOR) with 95% confidence intervals (CI) for mRS and risk ratios for secondary outcome measures. Results: We analyzed 1875 on-label, 2881 off-label, and 4639 non-treated patients. The most common off-label-criteria were mild symptoms (44.6%) and older age (33.6%). Off-label-treated patients had no worse functional outcome when compared to on-label-treated patients (cOR 0.89, CI 0.78–1.02), but better outcome compared to non-treated patients (cOR 0.83, CI 0.76–0.91). No associations were found for sICH or mortality. Conclusions: Our results suggest a beneficial effect of off-label treatment in clinical practice, which warrants further investigation into treatment in relevant subgroups and an extension of the product license.
- 1 December 2025
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 10 (4) , 1328-1336
Open AccessOff-label thrombolysis in acute ischemic stroke patients: Frequencies and outcome compared to on-label and no treatment
Background: Intravenous thrombolysis (IVT) is not approved for acute ischemic stroke in certain patient groups due to in- and exclusion criteria from mostly early clinical trials. In a real-life setting, we analyzed frequencies, outcomes and complications of off-label-IVT compared to on-label-IVT and no IVT to contribute to rational decision-making regarding patient selection for IVT. Methods: Patients in the Berlin Specific Acute Therapy in Ischemic or hAemorrhagic stroke with Long-term follow-up registry were divided into three groups (on-label, off-label, non-IVT-treated). Off-label criteria were age > 80 years, time from onset >4.5 h, mild (National Institutes of Health Stroke Scale [NIHSS] < 5) or severe (NIHSS > 25) stroke, and a history of prior stroke and diabetes mellitus, as those criteria applied during the study period. Outcomes of interest were the 90-day modified Rankin Scale (mRS), symptomatic intracranial hemorrhage (sICH), in-hospital- and 90-day-mortality. After multiple imputation, we performed multivariable logistic regression to calculate adjusted common odds ratios (cOR) with 95% confidence intervals (CI) for mRS and risk ratios for secondary outcome measures. Results: We analyzed 1875 on-label, 2881 off-label, and 4639 non-treated patients. The most common off-label-criteria were mild symptoms (44.6%) and older age (33.6%). Off-label-treated patients had no worse functional outcome when compared to on-label-treated patients (cOR 0.89, CI 0.78–1.02), but better outcome compared to non-treated patients (cOR 0.83, CI 0.76–0.91). No associations were found for sICH or mortality. Conclusions: Our results suggest a beneficial effect of off-label treatment in clinical practice, which warrants further investigation into treatment in relevant subgroups and an extension of the product license.
- 11 November 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (9) , e214225
Effect of Mobile Stroke Unit Dispatch on Process Parameters and Functional Outcomes in Patients With Acute Stroke
Prehospital stroke management on mobile stroke units (MSUs) shortens time to IV thrombolysis (IVT) and improves functional outcomes. Because IVT effects are time-dependent, optimizing workflows and dispatch-related processes may enhance MSU benefits. The B_PROUD-2.0 study aimed to determine the effect of additional MSU dispatch on functional outcomes in acute stroke patients under optimized MSU organization and service delivery. In the nonrandomized, controlled B_PROUD-2.0 study (May 2019-April 2021) conducted in Berlin, Germany, MSUs were simultaneously dispatched with conventional care ambulances for suspected stroke emergency calls, whenever available. We compared outcomes and process parameters between dispatch groups (additional MSU dispatch vs conventional care only) among patients with cerebral ischemia with disabling neurologic symptoms and no contraindications to reperfusion treatments. We used data from the Berlin dispatch center and records from the B_SPATIAL registry, consisting of 15 Berlin hospitals with stroke units. We performed pooled analyses with the B_PROUD-1.0 primary population (February 2017-April 2021) and with an extended cohort that also included patients with reperfusion treatment contraindications. The primary and co-primary outcomes were 3-month modified Rankin Scale scores (0: no deficits to 6: death) and 3-tiered disability scale scores. Effect estimates for these outcomes were obtained from ordinal logistic regressions, adjusting for a priori selected covariates after multiple imputation for missing values. Coronavirus disease 2019 pandemic and limited funding hindered full implementation of procedural improvements. A total of 1,050 patients (mean age: 74 years, 46.7% female) were included in B_PROUD-2.0 (vs 1,500 planned). We found no statistically significant effect of MSU dispatch on primary (common odds ratio [cOR] 0.90, 95% CI 0.72-1.14) or co-primary (cOR 0.86, 95% CI 0.63-1.17) outcomes in B_PROUD-2.0, and higher odds of IVT ≤1 hour of dispatch in the MSU group (OR 10.15, 95% CI 7.10-14.51). In pooled B_PROUD-1.0+2.0 primary population analyses (N = 2,666, mean age: 73 years, 46.8% female), we found a beneficial effect on primary (cOR 0.80, 95% CI 0.67-0.96) and co-primary (cOR 0.79, 95% CI 0.64-0.97) outcomes. The average effect on all stroke/TIA patients in the extended cohort (N = 4,336, mean age 75 years, 47.6% female) was also favorable (primary cOR 0.85, 95% CI 0.75-0.95; co-primary cOR 0.86, 95% CI 0.75-0.99). While we did not observe statistically significant differences in functional outcomes in the underpowered B_PROUD-2.0 study, we found beneficial effects considering both B_PROUD study periods, also when including all stroke/TIA patients. ClinicalTrials.gov: NCT03931616. Registered: April 26, 2019. First patient enrolled: May 9, 2019. The B_PROUD-2.0 study provides Class III evidence that the addition of MSUs to conventional care ambulances did not improve functional outcomes at 3 months compared with conventional care ambulances alone in patients with acute ischemic stroke.
- 11 November 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (9) , e214225
Effect of Mobile Stroke Unit Dispatch on Process Parameters and Functional Outcomes in Patients With Acute Stroke
Prehospital stroke management on mobile stroke units (MSUs) shortens time to IV thrombolysis (IVT) and improves functional outcomes. Because IVT effects are time-dependent, optimizing workflows and dispatch-related processes may enhance MSU benefits. The B_PROUD-2.0 study aimed to determine the effect of additional MSU dispatch on functional outcomes in acute stroke patients under optimized MSU organization and service delivery. In the nonrandomized, controlled B_PROUD-2.0 study (May 2019-April 2021) conducted in Berlin, Germany, MSUs were simultaneously dispatched with conventional care ambulances for suspected stroke emergency calls, whenever available. We compared outcomes and process parameters between dispatch groups (additional MSU dispatch vs conventional care only) among patients with cerebral ischemia with disabling neurologic symptoms and no contraindications to reperfusion treatments. We used data from the Berlin dispatch center and records from the B_SPATIAL registry, consisting of 15 Berlin hospitals with stroke units. We performed pooled analyses with the B_PROUD-1.0 primary population (February 2017-April 2021) and with an extended cohort that also included patients with reperfusion treatment contraindications. The primary and co-primary outcomes were 3-month modified Rankin Scale scores (0: no deficits to 6: death) and 3-tiered disability scale scores. Effect estimates for these outcomes were obtained from ordinal logistic regressions, adjusting for a priori selected covariates after multiple imputation for missing values. Coronavirus disease 2019 pandemic and limited funding hindered full implementation of procedural improvements. A total of 1,050 patients (mean age: 74 years, 46.7% female) were included in B_PROUD-2.0 (vs 1,500 planned). We found no statistically significant effect of MSU dispatch on primary (common odds ratio [cOR] 0.90, 95% CI 0.72-1.14) or co-primary (cOR 0.86, 95% CI 0.63-1.17) outcomes in B_PROUD-2.0, and higher odds of IVT ≤1 hour of dispatch in the MSU group (OR 10.15, 95% CI 7.10-14.51). In pooled B_PROUD-1.0+2.0 primary population analyses (N = 2,666, mean age: 73 years, 46.8% female), we found a beneficial effect on primary (cOR 0.80, 95% CI 0.67-0.96) and co-primary (cOR 0.79, 95% CI 0.64-0.97) outcomes. The average effect on all stroke/TIA patients in the extended cohort (N = 4,336, mean age 75 years, 47.6% female) was also favorable (primary cOR 0.85, 95% CI 0.75-0.95; co-primary cOR 0.86, 95% CI 0.75-0.99). While we did not observe statistically significant differences in functional outcomes in the underpowered B_PROUD-2.0 study, we found beneficial effects considering both B_PROUD study periods, also when including all stroke/TIA patients. ClinicalTrials.gov: NCT03931616. Registered: April 26, 2019. First patient enrolled: May 9, 2019. The B_PROUD-2.0 study provides Class III evidence that the addition of MSUs to conventional care ambulances did not improve functional outcomes at 3 months compared with conventional care ambulances alone in patients with acute ischemic stroke.
- Open Access
Neuroimaging Correlates of Post-Stroke Pain After Ischemic Stroke: Secondary Analysis of the INSPiRE-TMS Trial
Background Post-stroke pain (PSP) affects nearly half of stroke survivors, severely compromising quality of life. The causes of PSP remain underexplored, although there is likely a complex interplay of lesion effects, psychological factors and mobility that play a role in the development of PSP. The aim of the study was to investigate clinical characteristics associated with PSP, as well as structural and functional correlates of PSP using lesion symptom (LSM) and network mapping (LNM). Methods We analyzed data from the INSPiRE-TMS cohort, encompassing 1,022 minor ischemic stroke patients. Pain severity and psychological factors (EQ5D-3L questionnaire) were assessed annually for up to 3 years. In a sub-group of 391 patients with available imaging data, LSM and LNM analyses were conducted to identify neural correlates of PSP. Results Overall, 47% of patients reported pain 1-year post-stroke. Multivariable regression analyses identified baseline anxiety as being associated with PSP assessed at 1-year post-stroke (OR 2.90, 95% CI 1.17–7.17, p=0.021). LSM did not identify any voxels associated with new severe pain. LNM identified a network involving anterior cingulate cortex, thalamus and insular cortex. Adjusting for anxiety highlighted distinct network contributions, suggesting interactive effects of psychological states on pain perception. Automated comparison to large metanalytical findings using Neurosynth associated the terms ‘pain’ and ‘nociception’ most strongly to the identified network. Conclusion PSP is closely associated with psychological factors such as anxiety. LNM of PSP revealed disruptions in a pain-related neural network consistent with prior pain research. These results warrant external validation and could guide future network-targeted neuromodulation therapies. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT01586702.
Open AccessNeuroimaging Correlates of Post-Stroke Pain After Ischemic Stroke: Secondary Analysis of the INSPiRE-TMS Trial
Background Post-stroke pain (PSP) affects nearly half of stroke survivors, severely compromising quality of life. The causes of PSP remain underexplored, although there is likely a complex interplay of lesion effects, psychological factors and mobility that play a role in the development of PSP. The aim of the study was to investigate clinical characteristics associated with PSP, as well as structural and functional correlates of PSP using lesion symptom (LSM) and network mapping (LNM). Methods We analyzed data from the INSPiRE-TMS cohort, encompassing 1,022 minor ischemic stroke patients. Pain severity and psychological factors (EQ5D-3L questionnaire) were assessed annually for up to 3 years. In a sub-group of 391 patients with available imaging data, LSM and LNM analyses were conducted to identify neural correlates of PSP. Results Overall, 47% of patients reported pain 1-year post-stroke. Multivariable regression analyses identified baseline anxiety as being associated with PSP assessed at 1-year post-stroke (OR 2.90, 95% CI 1.17–7.17, p=0.021). LSM did not identify any voxels associated with new severe pain. LNM identified a network involving anterior cingulate cortex, thalamus and insular cortex. Adjusting for anxiety highlighted distinct network contributions, suggesting interactive effects of psychological states on pain perception. Automated comparison to large metanalytical findings using Neurosynth associated the terms ‘pain’ and ‘nociception’ most strongly to the identified network. Conclusion PSP is closely associated with psychological factors such as anxiety. LNM of PSP revealed disruptions in a pain-related neural network consistent with prior pain research. These results warrant external validation and could guide future network-targeted neuromodulation therapies. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT01586702.